The role of pulmonary vascular endothelial cell injury in COPD and its targeted therapeutic strategies
10.1097/st9.0000000000000080
- Author:
Xin JINGJING
1
;
Han NINGXIN
;
Chang LIPING
;
Jia ZHENHUA
Author Information
1. Graduate School,Hebei Medical University,Shijiazhuang,China;State Key Laboratory for Innovation and Transformation of Luobing Theory,Shijiazhuang,China
- Publication Type:Journal Article
- Keywords:
Chronic obstructive pulmonary disease;
Pulmonary vascular endothelial cells;
Mechanism of action;
Synthetic drugs and traditional Chinese medicine;
Targeted therapy
- From:
Science of Traditional Chinese Medicine
2025;3(3):199-209
- CountryChina
- Language:English
-
Abstract:
Chronic obstructive pulmonary disease(COPD)is a common disease with a high global incidence and mortality rate.It is charac-terized by chronic inflammation and structural airway obstruction that is not fully reversible,leading to shortness of breath caused by air trapping and increased physical exertion.Over the past few decades,the incidence of COPD has continued to rise.Although commonly used therapeutic agents,such as glucocorticoids and bronchodilators,have demonstrated significant symptomatic relief,they primarily target symptoms rather than halting disease progression.Therefore,further research is needed to better understand the underlying mechanisms of COPD and to develop novel therapeutic strategies for its prevention and management.Early studies on the pathogenesis of COPD primarily focused on airway epithelial cell injury,while relatively less attention was given to pulmonary vascular endothelial cells(PVECs).However,recent evidence indicates that COPD is not only an airway and systemic inflammatory disorder but also a vascular disease,with PVECs playing a critical role in its pathogenesis.PVECs are among the main cellular targets damaged in COPD and are involved in mediating its initiation and progression.In this review,we summarize emerging evidence that highlights the close association between PVEC injury and COPD pathogenesis.We also explore the roles and mechanisms of various therapeutic interventions targeting PVECs,including chemical agents and traditional Chinese medicine,in the treatment of COPD.
